.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 9,387,173

« Back to Dashboard

Details for Patent: 9,387,173

Title:Pharmaceutical formulation containing gelling agent
Abstract: Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient.
Inventor(s): Wright; Curtis (Rockport, MA), Oshlack; Benjamin (Boca Raton, FL), Breder; Christopher (Bethesda, MD)
Assignee: Purdue Pharma L.P. (Stamford, CT) The P.F. Laboratories, Inc. (Totowa, NJ) Purdue Pharmaceuticals L.P. (Wilson, NC)
Filing Date:Mar 16, 2015
Application Number:14/658,285
Claims:1. cited by applicant .
Paragraph IV Patent Certification Notice for ANDA 202372 (2011), pp. 1-34. cited by applicant .
Paragraph IV Patent Certification Notice for ANDA 202483 (2011), pp. 1-16. cited by applicant .
Paragraph IV Patent Certification Notice for ANDA 202762 (2011), pp. 1-22. cited by applicant .
Paragraph IV Patent Certification Notice for Amendment ANDA 202762 (2011), pp. 1-23. cited by applicant .
Paragraph IV Patent Certification Notice for ANDA 202455 (2011), pp. 1-16. cited by applicant .
Paragraph IV Patent Certification Notice for ANDA 202352 (2011), pp. 1-34. cited by applicant .
Paragraph IV Patent Certification Notice for ANDA 202352 (2013), pp. 1-16. cited by applicant .
Paragraph IV Patent Certification Notice for ANDA 202372 (2013), pp. 6-16. cited by applicant .
Paragraph IV Patent Certification Notice for ANDA 202434 (2013), pp. 7-12. cited by applicant .
Paragraph IV Patent Certification Notice for ANADA 202455 (2013), pp. 12-19. cited by applicant .
Paragraph IV Patent Certification Notice for ANDA 202483 (2013), pp. 1-7. cited by applicant .
Paragraph IV Patent Certification Notice for ANDA 203235 (2013), pp. 3-7. cited by applicant .
Ortho McNeil Janssen Pharmaceuticals, Inc. (2010) Prescribing Information for Concerta Extended Release Tablets, pp. 1-9. cited by applicant .
Apicella, et al., Poly(ethylene oxide) (PEO) Constant Release Monolithic Devices, Polymers in Medicine: Biomedical and Phaceitical Applications, Chapter 3 (1992), pp. 23-37. cited by applicant .
Apicella, et al., Poly(ethylene oxide)-Based Delivery Systems , Polymeric Drugs and Drug Administration, ACS Symposium Series 545, Chapter 9 (1994), pp. 111-125. cited by applicant .
The 1997 Physician's Desk Reference ("PDR") entry for Oxycontin.RTM., pp. 2163-2164. cited by applicant .
Complaint 1:13 cv 04606 (Jul. 2, 2013), pp. 1-11. cited by applicant .
Complaint 1:13 cv 01272 SHS (Feb. 25, 2013), pp. 1-34. cited by applicant .
Answer and Counterclaims 1:13-cv-01272-SHS (Mar. 8, 2013), pp. 1-11. cited by applicant .
Answer and Counterclaims 1:13-cvc-01272-SHS (Apr. 1, 2013), pp. 1-7. cited by applicant .
Consent Judgement: 13-cv-03188-SHS (May 10, 2013), pp. 1-7. cited by applicant .
Answer: Affirmative Defenses and Counterclaims 1:13-cv-03188-SHS (Jun. 7, 2013), pp. 1-43. cited by applicant .
Complaint 1:13-cv-03374-SHS (May 17, 2013), pp. 1-45. cited by applicant .
Answer and Counterclaims 1:13-cv-03374-SHS (Jun. 3, 2013), pp. 1-9. cited by applicant .
Complaint 1:13-cv-03372-SHS (May 17, 2013), pp. 1-32. cited by applicant .
IPR2016-01027, Petition for Inter Partes Review of U.S. Pat. No. 9,060,976), pp. 1-75, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1001, U.S. Pat. No. 9,060,976 (the '976 Patent), pp. 1-24, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1002, U.S. Pat. No. 8,337,888 (the '888 Patent), pp. 1-25, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1003, Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, No. 13-cv-3372-SHS (S.D.N.Y. Apr. 8, 2015.sub.--Finding of Facts and Conclusions of Law ("SDNY Decison"), pp. 1-69, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1004, Purdue Pharma L.P. et al. v. Amneal Pharmaceuticals LLC, No. 2015-1654 (Fed. Cir. Apr. 8, 2016) Order ("Federal Circuit Decision"), pp. 1-2, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1005, U.S. Pat. No. 8,101,630 ("Kumar Patent"), pp. 1-21, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1006, U.S. Patent Publication No. 2010/0216829 ("Kumar Publication"), pp. 1-23, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1007, Complaint, Purdue Pharma L.P. et al. v. Amneal Pharmaceuticlas LLC, 15-cv-831, filed Sep. 17, 2015, pp. 1-9, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1008, Complaint, Purdue Pharma L.P. et al. V. Amneal Pharmaceuticlas LLC, 15-cv1152, filed Dec. 15, 2015, pp. 1-36, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1009, Declaration of Dr. Anthony Palmieri ("Palmieri Declaration"), pp. 1-43, May 11, 2015. cited by applicant .
IPR2016-01027, Exhibit 1010, Curriculum Vitae of Anthony Palmieri, Ph.D., pp. 1-13, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1011, International Publication No. WO 99/32120 ("Palermo"), pp. 1-47, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1012, The Handbook of Pharmaceuticals Excipients pp. 399-400,655 (3.sup.rd ed. 2000), pp. 1-5, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1013, International Publication No. WO 97/49384 ("McGinity"), pp. 1-29, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1014, U.S. Patent Publication No. 2002/0187192 ("Joshi"), pp. 1-6, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1015. International Publication No. WO 95/20947 ("Bastin"), pp. 1-39, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1016. OxyContin, Physicians' Desk Reference pp. 2569-2574 (53.sup.rd ed. 1999), pp. 1-8, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1017, Purdue Pharma L.P. et al. v. Amneal Pharmaceuticlas LLC, No. 2014-1306,--1307 (Fed. Cir. Feb. 1, 2016), pp. 1-27, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1018, Department of Justice, Information Bulletin: OxyContin Diversion and Abuse (Jan. 2001), pp. 1-6, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1019, Barry Meier, U.S. Asks Painkiller Maker to Help Curb Wide Abuse, The New York Times (May 1, 2001), pp. 1-3, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1020, Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Pharmaceuticlas LLC, No. 2015-1654 (Fed. Cir. Aug. 12, 2015), pp. 1-198, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1021, Reply Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Pharmaceuticlas LLC, No. 2015-1654 (Fed. Cir. Dec. 23, 2016), pp. 1-41, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1022, U.S. Appl. No. 13/726,324, Originally Filed Specification, Dec. 24, 2012, pp. 1-62, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1023, U.S. Appl. No. 13/349,449, Originally Filed Specification, Jan. 12, 2012, pp. 1-62, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1024, U.S. Appl. No. 12/653,115, Originally Filed Specification, Dec. 8, 2009, pp. 1-62, Mat 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1025, U.S. Appl. No. 10/214,412, Originally Filed Specification, Aug. 6, 2002, pp. 1-62, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1026, U.S. Appl. No. 60/310,534, pp. 1-64, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1028, U.S. Appl. No. 13/726,324, Preliminary Amendment, Dec. 24, 2012, pp. 1-8, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1029, U.S. Appl. No. 13/726,324, Supplemental Amendment, Jan. 23, 2013, pp. 1-10, May 11, 2016. cited by applicant .
IRR2016-01027, Exhibit 1030, U.S. Appl. No. 13/726,324, Office Action, Jul. 15, 2013, pp. 1-10, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1031, U.S. Appl. No. 13/726,324, Amendment and Response, Jan. 15, 2014, pp. 1-27, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1032, U.S. Appl. No. 13/726,324, Notice of Allowance, Oct. 31, 2014, pp. 1-8, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1033, U.S. Appl. No. 13/726,324, Request for Continued Examination, Jan. 5, 2015, pp. 1-3, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1034, U.S. Appl. No. 13/726,324, Communication from Applicant, Jan. 29, 2015, pp. 1 of1, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1035, U.S. Appl. No. 13/726,324, Information Disclosure Statemtent, Apr. 14, 2015, pp. 1-8, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1036, U.S. Appl. No. 13/726,324, Notice of Allowance, May 12, 2015, pp. 1-9, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1037, U.S. Pat. No. 4,861,598 ("Oshlack"), pp. 1-5, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1038, U.S. Appl. No. 60/287,509 ("Josh Provisional"), pp. 1-14, May 11, 2016. cited by applicant .
IPR2016-01027, Exhibit 1039, Oral Dosage Forms, II (94) Remington: The Science and Practice of Pharmacy 1666-69 (19.sup.th ed. 1995), pp. 1-9, May 11, 2016. cited by applicant .
IPR2016-01028, Petition for Inter Partes Review of U.S. Pat. No. 9,060,976, pp. 1-76, May 11, 2016. cited by applicant .
IPR2016-00849, Petition for Inter Partes Review of U.S. Pat. No. 8,383,007, pp. 1-73, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1001, U.S. Pat. No. 8,389,007 to Curtis Wright, Benjamin Oshlack, and Christopher Breder, issued on Mar. 5, 2013, pp. 1-24, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1002, Expert Declaration of Arthur H. Kibbe (Dated Apr. 6, 2016), pp. 1-140, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1003, U.S. Pat. No. 8,337,888 to Curtis Wright, Benjamin Oshlack, and Christopher Breder, issued on Dec. 25, 2012, pp. 1-25, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1004, Purdue Pharma L.P., et al. v. Amneal Pharmaceuticals, LLC, No. 13-cv-3372 (SHS) (S.D.N.Y. Apr. 8, 2015) (Findings of Fact and Conclusions of Law), pp. 1-69, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1005, Physician Desk Reference, 54.sup.th Edition (2000), pp. 1-15, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1006, U.S. Pat. No. 2002/0187192 to Yatindra Joshi and Russell Somma, published on Dec. 12, 2012, pp. 1-6, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1007, U.S. Appl. No. 60/287509, filed on Apr. 30, 2001, pp. 1-15, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1008, U.S. Pat. No. 2003/0064122 to Michael Goldberg, Bradley Stuart Galer, Huai-Hung Kao, published on Apr. 3, 2003, pp. 1-7, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1009, U.S. Appl. No. 60/292809, filed May 23, 2001, pp. 1-12, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1010, U.S. Pat. No. 5,183,654 to Ulrich Speck and Peter Blaszkiewicz, issued on Feb. 2, 1993, pp. 1-6, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1011, U.S. Pat. No. 3,980,766 to Irving F. Shaw and Jerome Berk, issued on Sep. 14, 1976, pp. 1-5, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1012, U.S. Pat. No. 4,070,494 to Friedrich Hoffmeister, Rudolf Hiltmann, Hardmund Wollweber, and Helmut Kramer, issued on Jan. 24, 1978, pp. 1-6, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1013, U.S. Pat. No. 8,337,888 Prosecution File History (Notice of Allowance, filed Dec. 3, 2012), pp. 1-6, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1014, U.S. Appl. No. 60/310,534, filed Aug. 6, 2001, pp. 1-67, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1015, Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Pharmaceuticlas LLC, No. 2015-1654 (Fed. Cir. Aug. 12, 2015), pp. 1-198, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1016, Reply Brief of Plaintiffs-Appellants in Purdue Pharma L.P. et al. v. Amneal Pharmaceuticlas LLC, No. 2015-1654 (Fed. Cir. Dec. 23, 2016), pp. 1-41, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1017, Meier, "U.S. Asks Painkiller Maker to Help Curb Wide Abuse", NY times (May 1, 2001), pp. 1-3, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1018, Department of Justice, Information Bulletin: OxyContin Diversion and Abuse (Jan. 2001), pp. 1-6, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1019, U.S. Pat. No. 6,309,663 to Mahesh V. Patel and Feng-Jing Chen, issued on Oct. 30, 2001, pp. 1-55, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1020, International U.S. Appl. No. 99/44591 to David Edgren, Shu Li, Bhatti Gurdish, Patrick Wong and Robert Skluzacek, published on Sep. 10, 1999, pp. 1-57, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1021, U.S. Pat. No. 4,710,384 to Avner Rotman, issued on Dec. 1, 1987, pp. 1-6, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1022, U.S. Pat. No. 2002/0142039 to Charles David Claude, published on Oct. 3, 2002, pp. 1-9, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1023, Banker, Modern Pharmaceutics, 3.sup.rd Edition (1996), pp. 1-66, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1024, Kibbe, Handbook of Pharmaceutical Excipients, 3.sup.rd Edition (2000), pp. 1-18, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1025, U.S. Pat. No. 5,422,134 to Robert J. Hart, William M. Marrs, Judy A. White and Iain C. M. Dea, issued on Jun. 6, 1995, pp. 1-11, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1026, European Patent Application No. 0974345 to Young, Victor Morrison, pp. 1-4, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1027, Waugh, et. al., Peroperative Venography to Ensure Accurate Saphenopopliteal Vein Ligation, British Medical Journal (Jun. 28, 1090), pp. 1-2, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1028, Abdala, et al., Can HIV-1-Contaiminated Syringes Be Disinfected?, Journal of Acquired Immune Deficiency Syndromes 28:487-494 (2001), pp. 1-8, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1029, Needle, et al. HIV Risk Behaviors Associated with the Injection Process: Multiperson Use of Drug Injection Equipment and Paraphernalia in Injection Drug User Networks, Substance and Misuse 33:2401-2423 (1998), pp. 1-22, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1030, Neilloud, et al, Pharmaceutical Emulsions and Suspensions (2000), pp. 1-29, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1031, European Patent No. 0828802 to Paul J. Northey, issued on Jun. 25, 2003, pp. 1-17, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1032, Buhler, Kollidon : Polyvinylpyrrolidone for the Pharmaceutical Industry, 4th Edition (1998), pp. 1-288, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1033, U.S. Pat. No. 4,737,151 to John G. Clement and David R. Harker. Issued on Apr. 12, 1988, pp. 1-6, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1034, Chien, et al., Syringeability of Nonaqueous Parental Formulations- Development and Evaluation of a Testing Apparatus, PDA Journal of Science and Technology 35:281-284 (1981), pp. 1-6, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1035, Budavari, et al., The Merck Index, 12.sup.th Edition 1996, pp. 1-4, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1036, Maggi, et al. High Molecular Weight Polyethylene Oxides (PEOs) as an alternative to HPMC in controlled release dosage forms, International Journal of Pharmaceutics 195:229-238 (2000), pp. 1-10, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1037, The United States Pharmacopeia (2000), pp. 1-10, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1038, Mark, et al. Encyclopedia of Polymer Science and Engineering (1986), pp. 1-100, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1039, Poll, The Story of the Gauge, Anesthesia, 54:575-581, pp. 1-7, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1040, Bellingham, A reference Guide to insulin Pens, The Pharmaceutical Journal (Jun. 10, 2000), pp. 1-3, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1041, Purdue Pharma LP. et al. v. Acura Pharmaceuticals, Inc., 15-cv-00292-RGA (D.Del). (Egalet Proof Service), pp. 1-2, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1042, Purdue Pharma LP. et al. v. Acura Pharmaceuticals, Inc., 15-cv-00292-RGA (D.Del). (Acura Proof of Service), p. 1 of 1, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1043, Purdue Pharma LP., et al, v. Amneal Pharmaceuticals, LLC,No. 13-cv-3372 (SHS) (Trail Transcript on Jul. 14, 2014), pp. 1-198 Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1044, Bailey, et al. High Molecular Weight Polymers of Ethylene Oxide, Industrial and Engineering Chemistry 50:8-11 (1958), pp. 1-4, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1045, Gard, FDA Advisers Side Against Purdue's New Painkiller, Citing Dosing Dangers, FierceBiotech (Sep. 11, 2015), pp. 1-2, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1046, International U.S. Appl. No. 96/106,528 to James Ward, published on Mar. 7, 1996, pp. 1-66, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1047, International U.S. Appl. No. 95/186,02 to Mary Diabase and Howard Bernstein, published on Jul. 13, 1995, pp. 1-29, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1048, Markus, et al., Microscopic Air Embolism During Cerebral Angiography and Strategies for its Avoidance, The Lancet 341:784-87 (1993), pp. 1-4, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1049, U.S. Pat. No. 6,096,722 to C. Frank Bennett, Christopher K. Mirabelli, and Brenda Baker, issued on Aug. 1, 2000, pp. 1-85, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1050, Singh, et al. Transdermal Iontophoretic Delivery of Methylphenidate HCI in vitro, International Journal of Pharmaceutics 178:121-128 (1999), pp. 1-8, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1051, Webster's Third New International Dictionary (1986), pp. 1-3, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1052, Henderson's Dictionary of Biological Terms 10.sup.th Edition (1989), pp. 1-3, Apr. 6, 2016. cited by applicant .
IPR2016-00849, Exhibit 1053, Apicella, et al., Poly(ethylene oxide) (PEO) and Different Molecular Weight PEO Blends Monolithic Devices for Drug Release, Biomaterials 14:83-90 (1993), pp. 1-9, Apr. 6, 2016. cited by applicant.

Primary Examiner: Wax; Robert A
Assistant Examiner: Tcherkasskaya; Olga V
Attorney, Agent or Firm: Davidson, Davidson & Kappel, LLC
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc